中国药物经济学2023，Vol.18Issue(11)：5-10,16,7.DOI:10.12010/j.issn.1673-5846.2023.11.001
近十年中成药药物经济学研究文献分析及质量评价
Pharmacoeconomics Research Literature Analysis and Quality Evaluation of Chinese Patent Medicine in Recent Ten Years
摘要
Abstract
Objective By analyzing the evaluation factors of published Chinese patent medicine pharmacoeconomics literature and evaluating the literature quality,the existing problems in pharmacoeconomics research of Chinese patent medicine were explored.Methods Literature related to pharmacoeconomics of Chinese patent drugs published in CNKI、Wanfang、VIP、PubMed、Web of Science、Cochrane Library was searched,and the retrieval time was set from January 2012 to November 2022.The Consolidated Health Economic Evaluation Reporting Standards 2022(CHEERS 2022)was used to evaluate the quality by systematically organizing,concluding and analyzing key factors in economic evaluation,including research perspectives,research duration,discounting,thresholds,costs,health output indicators,evaluation methods,models and sensitivity analysis.Results Among the 288 literatures included,TCM injection was the most evaluated dosage form,and the comparison between different dosage forms of the same proprietary Chinese medicine was also included.The main diseases were cardiovascular and cerebrovascular diseases and respiratory diseases.The evaluation factor analysis showed that there were some problems in the pharmacoeconomics of PCM,such as unclear research Angle,simple cost calculation and single health output index.CHEERS evaluation showed that the literature quality was generally low,with an average score of 14.33(out of 28),and only 87 articles were qualified.Conclusion The overall report quality of Chinese patent medicine pharmacoeconomics research literature is poor.In the future,it is still necessary to strengthen the research on the core elements of pharmacoeconomics evaluation,constantly improve the quality of research and report,and integrate the evaluation elements of TCM characteristics,so as to promote the high-quality development of pharmacoeconomics research of Chinese patent medicine.关键词
中成药/质量评价/药物经济学/卫生经济学评价报告标准共识2022清单Key words
Chinese patent medicine/Quality evaluation/Pharmacoeconomics/CHEERS 2022分类
医药卫生引用本文复制引用
徐欢欢,苏鹏丽,郭文勇,刘骏,顾浩,于亚南,党海霞..近十年中成药药物经济学研究文献分析及质量评价[J].中国药物经济学,2023,18(11):5-10,16,7.基金项目
国家中医药管理局中医药标准化项目(GZY-FJS-2020-206) （GZY-FJS-2020-206）
首都医科大学医疗保障研究院开放性课题(YB2022B10) （YB2022B10）
